ATE344802T1 - Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure - Google Patents

Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure

Info

Publication number
ATE344802T1
ATE344802T1 AT01922679T AT01922679T ATE344802T1 AT E344802 T1 ATE344802 T1 AT E344802T1 AT 01922679 T AT01922679 T AT 01922679T AT 01922679 T AT01922679 T AT 01922679T AT E344802 T1 ATE344802 T1 AT E344802T1
Authority
AT
Austria
Prior art keywords
angiogenesis
nucleic acid
associated proteins
acid coding
sequence
Prior art date
Application number
AT01922679T
Other languages
English (en)
Inventor
Luca K Rastelli
Mary Gerritsen
Original Assignee
Curagen Corp
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Genentech Inc filed Critical Curagen Corp
Application granted granted Critical
Publication of ATE344802T1 publication Critical patent/ATE344802T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01922679T 2000-03-22 2001-03-22 Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure ATE344802T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19113400P 2000-03-22 2000-03-22

Publications (1)

Publication Number Publication Date
ATE344802T1 true ATE344802T1 (de) 2006-11-15

Family

ID=22704277

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01922679T ATE344802T1 (de) 2000-03-22 2001-03-22 Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure

Country Status (7)

Country Link
EP (2) EP1265920B9 (de)
JP (1) JP2004514404A (de)
AT (1) ATE344802T1 (de)
AU (3) AU4945001A (de)
CA (1) CA2403809A1 (de)
DE (1) DE60124380T2 (de)
WO (1) WO2001070808A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001070798A2 (en) * 2000-03-16 2001-09-27 K.U. Leuven Research & Development Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
CA2438483A1 (en) * 2001-02-16 2002-09-26 Merck Patent Gesellschaft Mit Beschraenkter Haftung Histidine phosphatase interacting protein with 240kd
JP2004537295A (ja) * 2001-06-01 2004-12-16 インサイト・ゲノミックス・インコーポレイテッド 核酸結合タンパク質
WO2010018764A1 (ja) * 2008-08-14 2010-02-18 国立大学法人愛媛大学 血管新生制御剤，及びそのスクリーニング方法，並びにスクリーニング用キット
JP5665213B2 (ja) * 2009-12-04 2015-02-04 国立大学法人愛媛大学 新規ユビキチンリガーゼ及びその利用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US4904582A (en) 1987-06-11 1990-02-27 Synthetic Genetics Novel amphiphilic nucleic acid conjugates
DE69008521T2 (de) 1989-03-07 1994-10-20 Genentech Inc Kovalente konjugate von lipiden und oligonukleotiden.
EP0471796A4 (en) 1989-05-10 1993-05-05 Sloan Kettering Institute For Cancer Research Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter
WO1991004753A1 (en) 1989-10-02 1991-04-18 Cetus Corporation Conjugates of antisense oligonucleotides and therapeutic uses thereof
CA2071483C (en) 1989-10-24 2001-04-17 Mark Matteucci Oligonucleotide analogs with novel linkages
JP2000512134A (ja) * 1996-05-31 2000-09-19 ザ ナショナル アメリカン レッド クロス Ｊａｇｇｅｄ／Ｎｏｔｃｈタンパク質および核酸に基づく治療および診断の方法および組成物
EP1165784A2 (de) * 1999-03-31 2002-01-02 Curagen Corporation Nukleinsäuren mit offener leserahmen, die polypeptiden kodieren; "orfx"
JP2003529325A (ja) * 1999-06-17 2003-10-07 インサイト・ゲノミックス・インコーポレイテッド ヒト輸送タンパク質

Also Published As

Publication number Publication date
EP1757618A3 (de) 2007-05-23
EP1265920B1 (de) 2006-11-08
DE60124380T2 (de) 2007-10-11
JP2004514404A (ja) 2004-05-20
EP1265920A2 (de) 2002-12-18
EP1757618A2 (de) 2007-02-28
WO2001070808A3 (en) 2002-05-10
AU4945001A (en) 2001-10-03
DE60124380D1 (de) 2006-12-21
EP1265920B9 (de) 2007-01-24
AU2006230637A1 (en) 2006-11-02
WO2001070808A2 (en) 2001-09-27
AU2001249450B2 (en) 2006-08-10
CA2403809A1 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
DE60141546D1 (de) Polypeptide enthaltend extrazellulären Domäne von IL-20RA und/oderr IL-20RB
DE60032367D1 (de) Aktivierbare rekombinante neurotoxine
SE8901687D0 (sv) Fibronectin binding protein as well as its preparation
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
DE69939553D1 (de) Charakterisierung der proteinfamilie von soc/crac kalziumkanälen
ATE462006T1 (de) Isoform des vegfs
EP1009814A4 (de) Kdr, ein menschlicher tyrosin kinase rezeptor
DE69528061D1 (de) Gereinigte polyporus laccasen und dafür kodierende nukleinsäuren
ATE184052T1 (de) Gdf-1 und uog1 proteine
DE60033138D1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
DE69839444D1 (de) Smad 6 und dessen anwendungen
ATE382685T1 (de) Bakteriophagen-lysin
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
ATE328073T1 (de) Ehrlichia canis protein
ATE534742T1 (de) Polypeptide und nukleinsäuren von phorphorymonas gingivalis
SE9801455D0 (sv) New receptor
NO882380D0 (no) Fibfonektin-bindende protein, samt fremstilling derav.
ATE403726T1 (de) Cytokin-proteinfamilie
BR0113099A (pt) Gene e proteìna relacionados com esquizofrenia
ATE344802T1 (de) Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure
SE9602822D0 (sv) New receptor
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
DE69739071D1 (de) Menschliche tak1 und für diese kodierende dna
LV12722A (lv) Prv-1 gene and the use thereof
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1265920

Country of ref document: EP